Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Defibrillators Pads Market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Defibrillators Padsindustry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Defibrillators Pads industry to benefit clients and increase the market sector. In recent years, the Defibrillators Pads industry has offered some of the most significant advantages to medicine. Major players in the Defibrillators Pads Market, including Medtronic, Cardiac Science Corporation, Koninklijke Philips N.V., Boston Scientific Corporation, Stryker Corporation Biotronik SE & Co. KG., Defibtech, LLC., Mindray Medical, Nihon Koden Corporation, Cardinal Health .
Nihon Kohden for instance, reported double-digit growth in international sales in 2020, due to the increased demand during the COVID-19 pandemic. Sales in Mexico and Colombia, in particular, recorded 200% growth due to surge in demand for Nihon Kohden's patient monitors, defibrillators, and ventilators. In June 2020, Philips received FDA clearance for HeartStartFRx and HeartStart FR3 automated external defibrillators. HeartStart FR3 includes innovative features to help medical personnel and first-responders treat cardiac arrest.
While HeartStartFRx is a public-access automated external defibrillators that features intuitive, step-by- step voice instructions, comprising cardiopulmonary resuscitation guidance, for emergency use in school, workplaces, and other public spaces, in addition to medical professional use.
The most important of these advancements development of automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). These devices help prevent cardiac attacks, with little or no external assistance irrespective of the time and location in case of any major variations in heartbeat. With technological improvements, operating a defibrillator has become easy for an observer post induction of proper training. For instance, in April 2019, Biotronik, Medical Device Company launched the Acticor device family of new implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators (CRT- Ds).
Boston Scientific, biomedical/biotechnology engineering firm and multinational manufacturer of medical devices launched the Resonate family of implantable cardioverter defibrillator and CRT-D systems in September 2017.
Leave a Comment